Creative Planning’s BioNTech BNTX Stock Holding History

Creative Planning’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$315K	Sell	3,381 -251	-7%	-$23.6K	﹤0.01%	3524
2026 Q1	$323K	Buy	+3,632	New	+$373K	﹤0.01%	3368
2023 Q2	–	Sell	-3,887	Closed	-$484K	–	2671
2023 Q1	$484K	Sell	3,887 -1,663	-30%	-$228K	﹤0.01%	1487
2022 Q4	$834K	Sell	5,550 -4,438	-44%	-$683K	﹤0.01%	1128
2022 Q3	$1.35M	Sell	9,988 -1,368	-12%	-$209K	﹤0.01%	833
2022 Q2	$1.69M	Sell	11,356 -8,457	-43%	-$1.29M	﹤0.01%	774
2022 Q1	$3.38M	Buy	+19,813	New	+$3.33M	0.01%	561

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Creative Planning's BNTX Position: Q2 2026 in Review

Creative Planning reduced its BioNTech (BNTX) stake by 6.9% in Q2 2026, selling an estimated $23.6K and leaving 3,381 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #3524.

Creative Planning first reported a position in BNTX in Q1 2022 and has held it in 7 quarters since. The position peaked at $3.38M in Q1 2022. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Creative Planning held 3,381 shares of BioNTech worth $315K as of Q2 2026.
Creative Planning sold 251 BioNTech shares in Q2 2026, an estimated $23.6K.
BioNTech made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #3524 holding.
Creative Planning first reported a position in BioNTech in Q1 2022 and has held it in 7 quarters since.
Creative Planning's BioNTech position peaked at $3.38M in Q1 2022.
283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.